[vc_row full_width=”stretch_row_content” klb_style=”overlaylight” el_class=”news-event-section”][vc_column klb_css_animation=”wow animated fadeInDown” offset=”vc_col-lg-offset-2 vc_col-lg-8″ css=”.vc_custom_1556669841265{margin-bottom: 50px !important;}”][title textalign=”center” title=”NEWS & EVENTS” subtitle=”We organize events for people to meet the leaders of GLO businesses. From investment briefings to chapter meetings, this is where you can find great alternative investments!” bordercolor=”rgba(0,0,0,0.2)”][/vc_column][vc_column offset=”vc_col-lg-8 vc_col-md-8″][vc_tta_tabs shape=”square” active_section=”1″][vc_tta_section title=”EVENTS” tab_id=”1476180581760-0a7999eb-e0df”]

Events

Load more events
[/vc_tta_section][vc_tta_section title=”INVEST” tab_id=”1476180604782-5feb1bfb-8dc5″][vc_row_inner css=”.vc_custom_1562195476820{margin-top: 0px !important;margin-bottom: 20px !important;}”][vc_column_inner offset=”vc_col-lg-4 vc_col-md-4″][vc_single_image image=”2313″ img_size=”full” onclick=”link_image” el_class=”custom_image”][vc_custom_heading text=”BBQ Franchise Rollout” font_container=”tag:h2|text_align:left|color:%23000000″ el_class=”project_title” link=”url:http%3A%2F%2F109.199.125.104%2F~glo%2Fportfolio%2Fbbq-franchise-rollout%2F|title:Innovation%20in%20Read-to-Drink%20Alcohol||”][btn_button btnalignment=”center” link=”url:https%3A%2F%2Finvest.withglo.com%2Fpub%2Foverview%3Fid%3D1lFqmCQr%26language%3Den|title:Learn%20More||”][/btn_button][/vc_column_inner][vc_column_inner offset=”vc_col-lg-4 vc_col-md-4″][vc_single_image image=”2320″ img_size=”300×222″ onclick=”link_image”][vc_custom_heading text=”Innovation in Alcohol” font_container=”tag:h2|text_align:left|color:%23000000″ el_class=”project_title” link=”url:http%3A%2F%2F109.199.125.104%2F~glo%2Fportfolio%2Finnovation-alcohol%2F|title:Innovation%20in%20Read-to-Drink%20Alcohol||”][btn_button btnalignment=”center” link=”url:https%3A%2F%2Finvest.withglo.com%2Fpub%2Foverview%3Fid%3DNrwegJ8h%26language%3Den|title:Learn%20More||”][/btn_button][/vc_column_inner][vc_column_inner offset=”vc_col-lg-4 vc_col-md-4″][vc_single_image image=”2310″ img_size=”full” onclick=”link_image” el_class=”custom_image”][vc_custom_heading text=”Needle-less Vaccines” font_container=”tag:h2|text_align:left|color:%23000000″ el_class=”project_title” link=”url:http%3A%2F%2F109.199.125.104%2F~glo%2Fportfolio%2Fneedle-less-vaccines%2F|title:Needle-less%20Vaccines||”][btn_button btnalignment=”center” link=”url:https%3A%2F%2Finvest.withglo.com%2Fpub%2Foverview%3Fid%3D158tcf4Q%26language%3Den|title:Learn%20More||”][/btn_button][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner offset=”vc_col-lg-4 vc_col-md-4″][vc_single_image image=”2307″ img_size=”300×222″ onclick=”link_image”][vc_custom_heading text=”Solar Mosquito Control” font_container=”tag:h2|text_align:left|color:%23000000″ el_class=”project_title” link=”url:http%3A%2F%2F109.199.125.104%2F~glo%2Fportfolio%2Fsolar-mosquito%2F|title:Solar%20Mosquito%20Control||”][btn_button btnalignment=”center” link=”url:https%3A%2F%2Finvest.withglo.com%2Fpub%2Foverview%3Fid%3DFpx6j7V2%26language%3Den|title:Learn%20More||”][/btn_button][/vc_column_inner][vc_column_inner offset=”vc_col-lg-4 vc_col-md-4″][/vc_column_inner][/vc_row_inner][/vc_tta_section][vc_tta_section title=”NEWS” tab_id=”1476180581737-194383b6-5433″][blog posts=”6″ categories=”all”][/vc_tta_section][/vc_tta_tabs][/vc_column][vc_column offset=”vc_col-lg-4 vc_col-md-4″][campaign_box image_url=”2310″ title=”PharmaJet” campaign_id=”2300″ duedate=”25 December 2019″]The innovative PharmaJet Stratis® Needle-Free Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines intramuscularly, subcutaneously, and intradermally, in addition to clinical claims for various vaccines. In particular, it has achieved a global claim demonstrating a superior immune response, using fractional dose intradermal delivery, as part of the Global Polio Eradication Initiative. PharmaJet’s technology has also demonstrated that its liquid “jet” injection can increase the immune response several-fold higher than traditional needle-based delivery, across a variety of infectious disease and cancer therapeutics, making it an essential tool for their regulatory approval and clinical claims.[/campaign_box][/vc_column][/vc_row]